Real-world Evidence From More Than 1000 Patients Treated With Adalimumab for Moderate-to-severe Psoriasis in The Czech Republic
mediaposted on 2021-02-26, 16:39 authored by Martina Kojanova, Petra Cetkovska, Daniela Strosova, Jorga Fialova, Petr Arenberger, Tomas Dolezal, Spyridon Gkalpakiotis, The BIOREP Study Group
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.